Physician profile
Sarah Doleeb
NPI 1659766566
$1,874.08
in general payments reported to CMS, 2019-2025
17 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $375 · 2021: $229 · 2022: $201 · 2023: $206 · 2024: $125 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424 · Travel and Lodging: $391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.73 |
| Travel and Lodging | $390.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $406.05 | 2022-2025 | Symplicity G3 |
| Abbott Laboratories | $271.36 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $267.95 | 2019-2023 | Lifevest |
| Amgen INC. | $156.58 | 2023 | Repatha |
| Abiomed | $150.45 | 2020-2021 | |
| Boston Scientific Corporation | $142.85 | 2019-2024 | Watchman Access System |
| Edwards Lifesciences Corporation | $81.47 | 2021-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $75.27 | 2021 | |
| Novartis Pharmaceuticals Corporation | $69.26 | 2025 | |
| Philips North America LLC | $55.70 | 2022 | |
| Terumo Medical Corporation | $53.90 | 2021-2022 | |
| Asahi Intecc USA, INC. | $37.76 | 2022 | |
| Biotronik INC. | $29.01 | 2022 | |
| Ani Pharmaceuticals, INC. | $23.82 | 2025 | Purified Cortrophin Gel |
| Getinge USA Sales, LLC | $19.40 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Circulation INC | $18.95 | 2019 | |
| Ekos Corporation | $14.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Doleeb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.